July 29, 2022
Urgent request: Ask cBHT prescribers to sign our physician letter to FDA!
If compounding hormones is a part of your compounding business, we know you’re concerned about FDA’s implicit threat to introduce restrictions. But do the prescribers you work with share that concern?
We’re hearing from members of Congress that they’ve heard a lot from pharmacists on this issue, but not much at all from physicians.
To address that issue, we’re asking for your help in engaging physicians in the campaign to save compounded hormones. If you have a database of cBHT prescribers, we’re asking you to reach out to them and urge them to sign a joint physician letter to FDA Commissioner Robert Califf (and to congressional leaders) expressing concern about FDA’s stated intention to rely on the discredited NASEM report in considering restrictions to compounded hormones.
The landing page we’ve created for this effort is http://www.a4pc.org/physicianletter.
Please click, then cut-and-paste the notice there into an email from you to your prescribers. The sign-on letter itself and the form for a physician to add their name to the letter are listed and linked at that landing page. This letter is ONLY for physicians, not for pharmacists or others.
Please share the message with prescribers pronto! The deadline for signing the letter is August 15.
